A tissue-bioengineering strategy for modeling rare human kidney diseases in vivo.

导出 OA

翻译打印收藏纠错

作者： J O R,Hernandez ^[1] ; X,Wang ^[1] ; M,Vazquez-Segoviano ^[1] ; M,Lopez-Marfil ^[1] ; M F,Sobral-Reyes ^[1] ; A,Moran-Horowich ^[1] ; M,Sundberg ^[2] ; D O,Lopez-Cantu ^[3] ; C K,Probst ^[1] ; G U,Ruiz-Esparza ^[4] ; K,Giannikou ^[5] ; R,Abdi ^[1] ; E P,Henske ^[3] ; D J,Kwiatkowski ^[4] ; M,Sahin ^[5] ; D R,Lemos ^[6]

作者单位： Renal Division, Brigham and Women's Hospital, Boston, MA, 02115, USA. ^[1] Rosamund Zander Stone Translational Neuroscience Center, Department of Neurology, Boston Children's Hospital, Boston, MA, 02115, USA. ^[2] Harvard Medical School, Boston, MA, 02115, USA. ^[3] Cancer Genetics Lab, Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA. ^[4] Center for LAM Research and Clinical Care, Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA. ^[5] Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. ^[6] Renal Division, Brigham and Women's Hospital, Boston, MA, 02115, USA. dlemos@bwh.harvard.edu. ^[7] Harvard Medical School, Boston, MA, 02115, USA. dlemos@bwh.harvard.edu. ^[8] Harvard Stem Cell Institute, Cambridge, MA, 02138, USA. dlemos@bwh.harvard.edu. ^[9]